Genvor Incorporated (GNVR)

Genvor Income Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Dec 31, 2021
Selling, General & Admin	5.95	2.54	1.36	0.8	0.65
Research & Development	0.46	0.24	0.08	0.01	0.23
Operating Expenses	6.41	2.78	1.44	4.52	3.1
Operating Income	-6.41	-2.78	-1.44	-4.52	-3.1
Interest Expense	-0.06	-0.02	-0.04	-0.11	-0.1
Other Non Operating Income (Expenses)	0.01	-0	-	-	-
EBT Excluding Unusual Items	-6.46	-2.8	-1.48	-4.63	-3.2
Merger & Restructuring Charges	-	-	-	-	-0.11
Other Unusual Items	0.87	-0.08	-0.23	-0.13	-0.12
Pretax Income	-5.59	-2.88	-1.71	-4.75	-3.44
Net Income	-5.59	-2.88	-1.71	-4.75	-3.44
Net Income to Common	-5.59	-2.88	-1.71	-4.75	-3.44
Shares Outstanding (Basic)	26	20	20	29	22
Shares Outstanding (Diluted)	26	20	20	29	22
Shares Change (YoY)	29.25%	1.71%	-33.36%	30.39%	218.63%
EPS (Basic)	-0.22	-0.15	-0.09	-0.16	-0.15
EPS (Diluted)	-0.22	-0.15	-0.09	-0.16	-0.15
Free Cash Flow	-0.56	-0.98	-0.86	-0.78	-0.66
Free Cash Flow Per Share	-0.02	-0.05	-0.04	-0.03	-0.03
EBITDA	-6.41	-2.78	-1.44	-4.52	-3.1
D&A For EBITDA	0	0	0	0	0
EBIT	-6.41	-2.78	-1.44	-4.52	-3.1
Advertising Expenses	0	0.08	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.